Results 121 to 130 of about 113,618,068 (200)

The evolving role of immunotherapy in ovarian cancer. [PDF]

Cancer
Veneziani AC, Venegas L, Oza AM.
europepmc   +1 more source

Patient-derived organoids as predictor of clinical response in ovarian cancer: a systematic review. [PDF]

Transl Oncol
Vegter M, Garkhail P, Nieuwenhuyzen-de Boer GM, Boere IA, van Beekhuizen HJ.   +4 more
europepmc   +1 more source

Ultrasound controllable and antigen-independent killing via <i>cis</i>-activating CAR T cells. [PDF]

Mol Ther Oncol
Zhu L, Cui J, Man CW, Mouchawar A, Yu X, Huang Y, Wu Y, Guo T, Xu H, Liu L, Wang Y.   +10 more
europepmc   +1 more source

Plasma proteomics-based liquid biopsy for predicting efficacy of PD-1-based immunochemotherapy in advanced gastric cancer: a prospective cohort study. [PDF]

Mol Biomed
Meng E, Cheng X, Wu X, Wang L, Ping X, Wang M, Ge M, Zhang X, Chen D, Zhu C, Li P, Wu H.   +11 more
europepmc   +1 more source

Antigen-Loaded and Calcium-Incorporated Chitosan Oligosaccharide Nanoparticles for Dendritic Cell Cross-Presentation and Immunotherapy. [PDF]

Int J Nanomedicine
Yu CP, Tsai JC, Shyong YJ.
europepmc   +1 more source

Immune checkpoint inhibitors in HIV infection: current evidence on viral reservoir regulation and immune restoration. [PDF]

Front Immunol
Wang Y, Huang X, Zheng L, Luo L, Li T, Cao W.   +5 more
europepmc   +1 more source

Bispecific antibodies are becoming the preferred standard of care in relapsed/refractory multiple myeloma. [PDF]

Blood Adv
Janakiram M.
europepmc   +1 more source

Multiplexed Detection of Cancer Protein Biomarkers via Surface-Enhanced Raman Scattering Immunoassays on Natural Diatomite Strips. [PDF]

Chemphyschem
Saridag AM, Karagoz ID, Wachsmann-Hogiu S, Kahraman M.   +3 more
europepmc   +1 more source